Medical

Australian experts on COVID-19 treatments

Health Industry Hub | March 23, 2020 |
[Total: 1    Average: 4/5]

Medical News: To date over 100 human clinical trials have been registered to assess different treatments against COVID-19. Australian experts share their views on the most promising candidates.

According to Dr Gaetan Burgio, from the John Curtin School of Medical Research at ANU, “A recent report demonstrated that anti HIV treatment doesn’t seem to work on COVID-19. There is lots of talk about the use of the antimalarial chloroquine or hydroxychloroquine as a possible treatment against COVID-19. However as the results of the clinical trials are inconclusive and debated, it is too early to tell whether these antimalarials would be efficacious against COVID-19. As hydroxychloroquine is widely used to treat patients with Lupus, I urge people not to stockpile this medicine so that Lupus patients can be treated.”

HCP engagement during COVID-19 – solutions developed by industry for industry. Learn more about how we can help your team by combining our expertise in delivering and measuring the engagement from digital health content, with 20+ years industry experience.

“We ultimately need to find a vaccine, which will be the most effective way of stopping the spread. The vaccine needs to be developed and tested, going through the phases of a drug trial I through to III. All other treatments may have antiviral components, which helps speeds up the process of getting well, but this virus is no different to influenza or the common cold. We don’t have a one-size-fits-all drugs that fixes all viruses.” commented Professor Bruce Thompson, Dean of Health at Swinburne University.

Dr Phillip Reece, an Honorary Senior Fellow in the Department of Pharmacology and Therapeutics at the University of Melbourne, said “Remdesivir is an experimental treatment developed by Gilead. It was being developed for Ebola infections and has shown activity against COVID-19 in laboratory experiments.  It is not marketed and has been made available on a compassionate use basis to treat at least two patients with COVID-19 infections. It appeared to be effective in these cases but I have not seen the evidence. Clinical trials are underway in China and elsewhere with remdesivir to establish its efficacy against COVID-19 infections in a larger number of patients. It may be some weeks or months before we know the results of these trials.
 
“Clinical studies are also underway to determine whether some marketed treatments for HIV (lopinavir and ritonavir) are effective against COVID-19 infections. Together with another marketed drug, ribavirin, they may be effective when used in combination against COVID-19. Again results from these trials are some way off.

As for a cure, it is possible that some of these drugs and their combinations might reduce the severity and duration of symptoms of COVID-19 infections in patients if started early. This is much like the situation with influenza where administration of antivirals such as Relenza and Tamiflu within 48 hours of the first signs of the infection, can reduce the duration of symptoms by up to two or three days. Relenza and Tamiflu have also been shown to reduce morbidity and reduce mortality.” he concluded.

Register FREE and join 20,000+ industry professionals who receive the latest industry news, innovations and insights from Health Industry Hub; the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.


About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

News & Trends - Medical Technology

MedTech news - New 5 minute coronavirus test delivers clear results on infection

New 5 minute coronavirus test delivers clear results on infection

Health Industry Hub | April 9, 2020 |

A new type of sensor device from the German health technology company Digital Diagnostics AG can be used for immediate […]

More


Marketing & Strategy

Marketing & Strategy in Healthcare - Customer-Centric Engagement During COVID-19

Customer-Centric Engagement During COVID-19

Health Industry Hub | April 8, 2020 |

Navigating the multichannel maze in COVID 19 times to engage healthcare professionals (HCPs) and patients has been challenging for most […]

More


News & Trends - Medical Technology

MedTech News - Stryker launches limited-release medical bed to support critical needs during COVID-19 pandemic

Stryker launches limited-release medical bed to support critical needs during COVID-19 pandemic

Health Industry Hub | April 8, 2020 |

MedTech News: Stryker has developed a low-cost, limited-release emergency response bed to quickly aid healthcare providers with efficient care during […]

More


Medical

Medical News - AMA urges Australians to continue with ongoing medical care amid COVID-19 crisis

AMA urges Australians to continue with ongoing medical care amid COVID-19 crisis

Health Industry Hub | April 8, 2020 |

Medical News: The AMA is urging people to keep a close watch on their ongoing health care and maintenance, and […]

More